These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18686364)

  • 21. Oncogene addiction and non-oncogene addiction in glioblastoma therapy.
    Ng K; Chen CC
    Chin Med J (Engl); 2011 Sep; 124(17):2565-8. PubMed ID: 22040404
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genes associated with tobacco smoke-associated cancer of head and neck].
    Szyfter K; Giefing M; Jarmuz M; Kostrzewska-Poczekaj M
    Przegl Lek; 2008; 65(10):680-3. PubMed ID: 19189577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing gene therapy for head and neck cancer communicating bench to bedside.
    Clayman GL
    Acta Otorhinolaryngol Belg; 1999; 53(3):189. PubMed ID: 10635390
    [No Abstract]   [Full Text] [Related]  

  • 24. Contemporary diagnosis and management of head and neck cancer.
    Spiegel JH; Jalisi S
    Otolaryngol Clin North Am; 2005 Feb; 38(1):xiii-xiv. PubMed ID: 15649493
    [No Abstract]   [Full Text] [Related]  

  • 25. [Genetic basis of head and neck cancers and gene therapy].
    Özel HE; Özkırış M; Gencer ZK; Saydam L
    Kulak Burun Bogaz Ihtis Derg; 2013; 23(2):127-32. PubMed ID: 23611329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does pharma fund the pipers? - Scottish Intercollegiate Guidelines Network (SIGN) guidelines 90 - diagnosis and management of head and neck cancer, October 2006.
    Wilson JA
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):661-3. PubMed ID: 18450433
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting important pathways in head and neck cancer: from the bench to the clinic.
    Santos ES; Perez C; Donald CE; Raez LE
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER2 Polysomy in aggressive head and neck cutaneous squamous cell carcinoma.
    Low I; Ch'ng S; Ng D; Sullivan M; Brasch H; Davis P; Tan ST
    Hum Pathol; 2009 Jun; 40(6):902-3. PubMed ID: 19269011
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.
    McLaughlin PJ; Kreiner S; Morgan CR; Zagon IS
    Int J Oncol; 2008 Oct; 33(4):751-7. PubMed ID: 18813788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
    Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
    Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock protein 70, erythropoietin, and cancer.
    Sizer KC
    J Clin Oncol; 2007 Sep; 25(27):4326; author reply 4326-7. PubMed ID: 17878490
    [No Abstract]   [Full Text] [Related]  

  • 34. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. True identity by immunohistochemistry and molecular morphology of undifferentiated malignancies of the head and neck.
    Carbone A; Gloghini A; Rinaldo A; Devaney KO; Tubbs R; Ferlito A
    Head Neck; 2009 Jul; 31(7):949-61. PubMed ID: 19378322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
    Singh AP; Shah PP; Ruwali M; Mathur N; Pant MC; Parmar D
    Cancer Invest; 2009 Oct; 27(8):869-76. PubMed ID: 19639480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
    Xu F; Li S; Li XL; Guo Y; Zou BY; Xu R; Liao H; Zhao HY; Zhang Y; Guan ZZ; Zhang L
    Cancer Gene Ther; 2009 Sep; 16(9):723-30. PubMed ID: 19363470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current status and future prospect of head and neck cancer therapy--from the viewpoint of a pathologist].
    Nihon Jibiinkoka Gakkai Kaiho; 2005 Feb; 108(2):135-41. PubMed ID: 15765726
    [No Abstract]   [Full Text] [Related]  

  • 40. [Gene therapy of head and neck neoplasms].
    Li XM; Song Q
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jun; 42(6):473-6. PubMed ID: 17702432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.